AAM Working To Mitigate Coronavirus Effects

US Association Says Contingency Planning Is A ‘Top Priority’

The US Association for Accessible Medicines says it is actively working with industry stakeholders to mitigate coronavirus-related disruptions to the off-patent industry’s supply chain, with contingency planning a “top priority.”

Coronavirus
The AAM is working to mitigate the US impact of coronavirus on the off-patent supply chain • Source: Shutterstock

More from Regulation

More from Policy & Regulation